Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2006
05/04/2006US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases
05/04/2006DE102004053023A1 Pharmaceutical formulation useful for treating inflammatory and obstructive respiratory diseases comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic
05/04/2006DE102004052987A1 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives
05/04/2006CA2585657A1 Sophorae subprostratae radix extract for prevention and treatment of respiratory diseases
05/04/2006CA2585122A1 M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
05/03/2006EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition
05/03/2006EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors
05/03/2006EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors
05/03/2006EP1651638A1 Pyridyl piperazinyl ureas
05/03/2006EP1651636A1 Substituted heterocyclic diarylamine analogues
05/03/2006EP1651635A1 Nicotinamide derivatives useful as pde4 inhibitors
05/03/2006EP1651610A1 Quinoline derivates and their use in therapy
05/03/2006EP1651342A2 Combinatorial synthesis on support
05/03/2006EP1651271A2 Compositions and methods for treating coronavirus infection and sars
05/03/2006EP1651270A1 Medicaments for inhalation comprising betamimetics and an anticholinergic
05/03/2006EP1651236A1 Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
05/03/2006EP1651230A1 Medicaments for inhalation comprising steroids and a novel anticholinergic
05/03/2006EP1651224A1 Medicaments for inhalation comprising anticholinergics and a betamimetic
05/03/2006EP1651222A1 Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
05/03/2006EP1651221A1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent
05/03/2006EP1651208A1 Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
05/03/2006EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
05/03/2006EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
05/03/2006EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
05/03/2006EP1389129A4 Methods of treating respiratory conditions
05/03/2006EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
05/03/2006EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses
05/03/2006EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
05/03/2006EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands
05/03/2006EP1139755B1 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
05/03/2006EP0937069B1 Piperazino derivatives as neurokinin antagonists
05/03/2006EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides
05/03/2006CN2776404Y Chinese herbal medicine plaster for treating cough asthma disease by acupoint compress
05/03/2006CN1768140A A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS)
05/03/2006CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
05/03/2006CN1767842A Method for the production of an extract of ivy leaves
05/03/2006CN1767839A Antiallergic composition
05/03/2006CN1767828A Medicinal composition
05/03/2006CN1767827A Remedy and/or preventive for lung diseases
05/03/2006CN1765929A Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses
05/03/2006CN1765416A Health caring plaster
05/03/2006CN1765390A Chinese medicine for treating pulmonary heart disease
05/03/2006CN1765371A Spleen extracts, its preparation method and use
05/03/2006CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype
05/03/2006CN1254478C Derivatives of monosaccharides as well adhesion inhibitors
05/03/2006CN1254475C 5-methoxy-8-aryl-[1,2,4]triazolo[1,5-a]pyridine derivatives as adenosine receptor antagonists
05/03/2006CN1254262C Compound cold-treating tablet and its manufacturing method
05/03/2006CN1254254C Proprietary Chinese traditional medicine for treating nasosinusitis
05/03/2006CN1254236C Lyophilized preparation of civeleth sodium
05/03/2006CN1254235C Manufacturing technique of fine Fanhuncao granula formulation
05/02/2006USRE39088 Amide compounds and use of the same
05/02/2006US7038073 Synthesis of 2-alkyl amino acids
05/02/2006US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
05/02/2006US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering
05/02/2006US7038029 Vaccination
05/02/2006US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/02/2006US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides
05/02/2006US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases
05/02/2006US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia
05/02/2006US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists
05/02/2006US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis
05/02/2006US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases
05/02/2006US7037701 Genetic engineering; detection moderators of kinase peptidespeptides
05/02/2006US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction
05/02/2006US7037665 Compositions comprising SNORF36 receptor compounds
05/02/2006US7037533 Functional agent for decomposing nicotine and method of preparing the same
05/02/2006CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
05/02/2006CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
04/2006
04/27/2006WO2006044412A1 Novel b1 bradykinin receptor antagonists
04/27/2006WO2006044133A1 Active ketone inhibitors of tryptase
04/27/2006WO2006043846A1 Salt of montelukast with tert.-butylamine
04/27/2006WO2006043722A1 Chimeric (double) decoy
04/27/2006WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO
04/27/2006WO2006043655A1 Medicinal composition for inhalation
04/27/2006WO2006042950A2 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
04/27/2006WO2006042949A1 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
04/27/2006WO2006042948A1 Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
04/27/2006WO2006023396A3 Vla-4 antagonists
04/27/2006WO2006002453A3 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
04/27/2006US20060089497 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
04/27/2006US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
04/27/2006US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
04/27/2006US20060089375 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
04/27/2006US20060089362 N-(2- piperazinophenyl) methyl 3-(3-chlorophenyl)-pyrazolo-[1,5-a]-pyrimidine-6-amide; treats circulatory diseases such as diseases due to inflammation, circulatory disorders, enhanced proliferation activities, and the like, i.e., hypertension, diabetes, diabetic complications, arteriosclerosis
04/27/2006US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient
04/27/2006US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same
04/27/2006US20060089336 4-Dedimethylamino tetracycline compounds
04/27/2006US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists
04/27/2006US20060089326 Immunostimulatory nucleic acid molecules
04/27/2006US20060088534 Human anti-factor ix/ixa antibodies
04/27/2006US20060088513 Antiallergic composition
04/27/2006CA2584195A1 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
04/27/2006CA2584178A1 Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
04/27/2006CA2583986A1 Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists
04/27/2006CA2583576A1 Chimera (double) decoy
04/27/2006CA2583363A1 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells
04/27/2006CA2583267A1 Novel b1 bradykinin receptor antagonists
04/26/2006EP1650218A1 The artificial cpg single strand deoxidation oligonucleotide and its antiviral uses
04/26/2006EP1650205A1 Cyclohexanecarboxylic acid compound
04/26/2006EP1650199A1 Sulfonamide derivative having isoxazole ring